Skip to main content
Equibles

Quadrature Capital Ltd

Position in KPTI — Karyopharm Therapeutics Inc.

CIK 1651424 LONDON, X0
Back to KPTI Full portfolio

Position in KPTI

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$100,591
-$338,859 QoQ
Shares Held
10,296
-82.8% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 96 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in KPTI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Quadrature Capital Ltd holds $196,879,210 across 154 Biotechnology names. KPTI ranks #126 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 49,073 $30,598,978
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 46,945 $23,318,989
3 RVMD
Revolution Medicines, Inc.
 92,717 $17,364,039
4 ASND
Ascendis Pharma A/S
 40,845 $10,894,178
5 ONC
BeOne Medicines Ltd.
 29,203 $8,321,978
6 ALNY
Alnylam Pharmaceuticals, Inc.
 22,653 $6,819,232
7 BNTX
BioNTech SE
 67,965 $6,324,143
8 INSM
INSMED Inc
 48,355 $5,155,610

All Filings in KPTI

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $100,591 10,296
2025-12-31 $439,450 59,708